I am a radiologist who specializes in body imaging. My role in the multidisciplinary care of patients at Memorial Sloan Kettering involves diagnosis, staging, and follow-up.
In addition to my clinical and teaching responsibilities, I have a particular interest in research on gynecologic malignancies and participate in the Gynecologic Disease Management Team.
- Clinical Expertise: Cross-Sectional Imaging: CT, MRI, Ultrasound
- Languages Spoken: English
- Education: MD, Albany Medical College
- Residencies: University of Texas, Houston, Medical School
- Fellowships: Columbia Presbyterian Medical Center; Beth Israel Deaconess Medical Center
- Board Certifications: Diagnostic Radiology
Kaufman HS, Buller JL, Thompson JR, Pannu HK, DeMeester SL, Genadry RR, Bluemke DA, Jones B, Rychcik JL, Cundiff GW. Dynamic pelvic magnetic resonance imaging and cystocolpoproctography alter surgical management of pelvic floor disorders. Dis Colon Rectum 2001; 44(11):1575-1584.
Bristow RE, Simpkins F, Pannu HK, Fishman EK, Montz FJ. Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer. Gynecol Oncol 2002; 85(1):196-200.
Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL, Montz FJ. Clinically Occult Recurrent Ovarian Cancer: Patient Selection for Secondary Cytoreductive Surgery Using Combined PET/CT. Gynecol Oncol 2003; 90(3):519-528.[pmis:13678719]
Bristow RE, Giuntoli RL 2nd, Pannu HK, Schulick RD, Fishman EK, Wahl RL. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 2005; 99(2):294-300.
Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M, Schwartz LH, Woodward P, Pannu H, Hricak H. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 2006; 24(36):5687-5694.
Goetze S, Pannu HK, Wahl RL. Clinically significant abnormal findings on the “nondiagnostic” CT portion of low-amperage-CT attenuation-corrected myocardial perfusion SPECT/CT studies. J Nucl Med 2006; 47(8):1312-1318.
Hricak H, Gatsonis C, Coakley FV, Snyder B, Reinhold C, Schwartz LH, Woodward PJ, Pannu HK, Amendola M, Mitchell DG. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007; 245(2):491-498.
Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola MA, Schwartz LH, Woodward P, Pannu H, Atri M, Hricak H. Early Invasive Cervical Cancer: MRI and CT Predictors of Lymphatic Metastases in the ACRIN 6651 / GOG 183 Intergroup Study. Gynecol Oncol. 2009;112(1):95-103.
Pannu HK, Scatarige JC, Eng J. Comparison of supine MRI with and without rectal contrast to fluoroscopic cystocolpoproctography for the diagnosis of pelvic organ prolapse. J Comput Assist Tomogr. 2009; 33(1):125-30.
Pannu HK, Ma W, Zabor EC, Moskowitz CS, Barakat RR, Hricak H. Enhancement of ovarian malignancy on clinical contrast enhanced MRI studies. ISRN Obstet Gynecol. 2013; 2013:979345. doi: 10.1155/2013/979345. Epub 2013 Feb 13.
Harris RD, Javitt MC, Glanc P, Brown DL, Dubinsky T, Harisinghani MG, Khati NJ, Kim YB, Mitchell DG, Pandharipande PV, Pannu HK, Podrasky AE, Royal HD, Shipp TD, Siegel CL, Simpson L, Wall DJ, Wong-You-Cheong JJ, Zelop CM. ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass. Ultrasound Q. 2013 Mar;29(1):79-86 [pmid:23358212]]
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more